PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Harvard Pilgrim Health CareMedicaid · Coverage · Provider Newsletter · MA · Rheumatology, Gastroenterology, DermatologyHigh impact

Reminder: preferred biosimilars to Humira and Stelara

Act
by Mar 31, 2026
Effective date
Jan 5, 2026
Identified
Jun 20, 2026

Summary

MassHealth is transitioning from Humira and Stelara to preferred biosimilars effective January 5, 2026, with a grace period through March 31, 2026. After April 1, 2026, Humira and Stelara will require step therapy (trying preferred biosimilars first) and new prior authorizations for patients who haven't switched.

Get alerts when payers change rules like this one

We check Harvard Pilgrim Health Care and other payers every day and email you when a change matches your specialty and state.

Get Harvard Pilgrim Health Care alertsPolicy Monitoring is free. No card required.

What to do

by Mar 31, 2026 · 3 steps
01Billing team must identify all patients on Humira and Stelara and coordinate with providers to transition them to preferred biosimilars (Hadlima, adalimumab-adaz for Humira; Pyzchiva, Imuldosa, or Steqeyma for Stelara).
02Update prior authorization workflows in billing system for April 1, 2026 to require step therapy documentation for Humira/Stelara requests.
03Note that Imuldosa requires new prescriptions while others can be pharmacy-substituted.

Original notice

Reminder: preferred biosimilars to Humira and Stelara
point32health.org · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account